Julien Blouin

Stock Analyst at Goldman Sachs

(2.11)
# 2,929
Out of 5,152 analysts
28
Total ratings
42.86%
Success rate
-0.91%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Jan 20, 2026
Maintains: Sell
Price Target: $33$38
Current: $37.67
Upside: -0.45%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $17.41
Upside: -2.35%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $309.36
Upside: +31.56%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $108.64
Upside: -2.43%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $29.99
Upside: +23.37%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $13.25
Upside: +50.94%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $30.66
Upside: +2.74%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $26.42
Upside: +62.76%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $14.69
Upside: +15.76%
Colliers International Group
Mar 19, 2025
Maintains: Neutral
Price Target: $165$145
Current: $119.09
Upside: +21.76%
Initiates: Buy
Price Target: $176
Current: $141.19
Upside: +24.65%
Initiates: Neutral
Price Target: $318
Current: $258.24
Upside: +23.14%
Initiates: Neutral
Price Target: $81
Current: $63.11
Upside: +28.35%
Initiates: Buy
Price Target: $187
Current: $134.41
Upside: +39.13%